[A strange pulmonary embolism].

Rev Med Interne

Service de pneumologie, hôpital Foch, Suresnes, France.

Published: July 2005

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0248-8663(05)81291-3DOI Listing

Publication Analysis

Top Keywords

strange pulmonary
4
pulmonary embolism]
4
strange
1
embolism]
1

Similar Publications

Importance: The optimal configuration of a smoking cessation intervention in a lung cancer screening (LCS) setting has not yet been established.

Objective: To evaluate the efficacy of 3 tobacco treatment strategies of increasing integration and intensity in the LCS setting.

Design, Setting, And Participants: In this randomized clinical trial, LCS-eligible current smokers were randomized into 3 treatments: quitline (QL), QL plus (QL+), or integrated care (IC).

View Article and Find Full Text PDF

Background: Despite guideline recommendations, most patients with COPD do not undergo alpha-1 antitrypsin deficiency (AATD) testing and approximately 90% of people with AATD in the US remain undiagnosed. This study sought to develop a predictive model using real-world data to improve detection of AATD-positive patients in the general COPD population.

Methods: A predictive model using XGBoost was developed using the EVERSANA database, including longitudinal, patient-level medical claims, prescription claims, AATD-specific testing data, and electronic health records (EHR).

View Article and Find Full Text PDF
Article Synopsis
  • The study investigates the prevalence and impact of pulmonary hypertension (PHT) in adults with left ventricular diastolic dysfunction (LVDD) and preserved ejection fraction, using a large database of 16,058 patients.
  • Findings indicate that nearly 84% of subjects had some form of PHT, correlating higher tricuspid regurgitation velocity (TRV) levels with increased mortality rates over 1 and 5 years.
  • The research highlights that the risk of death increases significantly with higher TRV levels, establishing a clear prognostic relationship between PHT severity and mortality, particularly noted at TRV levels above 2.9 m/s.
View Article and Find Full Text PDF

Pathologic differences between systemic sclerosis-associated and idiopathic pulmonary arterial hypertension.

J Scleroderma Relat Disord

November 2024

Division of Pulmonary, Critical Care, Allergy and Sleep Medicine, Department of Medicine, Medical University of South Carolina, Charleston, SC, USA.

Article Synopsis
  • * A study compared lung tissue samples from patients with systemic sclerosis-associated PAH, idiopathic PAH, and healthy controls to identify differences in lung pathology and treatment response.
  • * Findings showed that idiopathic PAH has plexiform lesions present, while systemic sclerosis-associated PAH has significantly worse interstitial fibrosis and cellularity, but similar levels of smooth muscle hypertrophy.
View Article and Find Full Text PDF
Article Synopsis
  • - The study aimed to examine how a 'mitral-specific' cardiac damage score (m-CDS) relates to survival outcomes in patients with mitral regurgitation (MR) and compared it with an 'aortic-specific' cardiac damage score (a-CDS) using data from a large Australian database.
  • - Out of over 620,000 adults analyzed through echocardiography, about 17,658 (3.1%) had moderate or severe MR, and a subset of 5,000 patients was tested to evaluate the effectiveness of various CDS models in predicting all-cause mortality over an average follow-up of 3.8 years.
  • - The research revealed that higher m-CDS stages were linked to
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!